Search Results - "Frizelle, Sandra"

Refine Results
  1. 1

    A comparison of DigiGait™ and TreadScan™ imaging systems: assessment of pain using gait analysis in murine monoarthritis by Dorman, Christopher W, Krug, Hollis E, Frizelle, Sandra P, Funkenbusch, Sonia, Mahowald, Maren L

    Published in Journal of pain research (01-01-2014)
    “…Carrageenan-induced arthritis is a painful acute arthritis model that is simple to induce, with peak pain and inflammation occurring at about 3 hours. This…”
    Get full text
    Journal Article
  2. 2

    The effect of intra-articular vanilloid receptor agonists on pain behavior measures in a murine model of acute monoarthritis by Abdullah, Mishal, Mahowald, Maren L, Frizelle, Sandra P, Dorman, Christopher W, Funkenbusch, Sonia C, Krug, Hollis E

    Published in Journal of pain research (01-01-2016)
    “…Arthritis is the most common cause of disability in the US, and the primary manifestation of arthritis is joint pain that leads to progressive physical…”
    Get full text
    Journal Article
  3. 3

    Gene expression profiling identifies matriptase overexpression in malignant mesothelioma by Hoang, Chuong D, D'Cunha, Jonathan, Kratzke, Marian G, Casmey, Carrie E, Frizelle, Sandra P, Maddaus, Michael A, Kratzke, Robert A

    Published in Chest (01-05-2004)
    “…We investigated the gene expression profiles of malignant pleural mesothelioma (MPM) specimens to identify novel genes that are potentially involved in the…”
    Get more information
    Journal Article
  4. 4

    Pain Behavior Measures to Quantitate Joint Pain and Response to Neurotoxin Treatment in Murine Models of Arthritis by Krug, Hollis E., Frizelle, Sandra, McGarraugh, Pari, Mahowald, Maren L.

    Published in Pain medicine (Malden, Mass.) (01-10-2009)
    “…ABSTRACT Objective.  To evaluate the validity of newly developed pain behavior measures in two murine models of inflammatory arthritis and to determine the…”
    Get full text
    Journal Article
  5. 5

    Ras pathway activation in malignant mesothelioma by Patel, Manish R, Jacobson, Blake A, De, Arpita, Frizelle, Sandra P, Janne, Pasi, Thumma, Saritha C, Whitson, Brian A, Farassati, Faris, Kratzke, Robert A

    Published in Journal of thoracic oncology (01-09-2007)
    “…Mutations in Ras family genes are rare in malignant mesothelioma. The role of activation of the Ras signaling pathway in the pathogenesis of mesothelioma is…”
    Get more information
    Journal Article
  6. 6

    Human lung carcinomas express Fas ligand by NIEHANS, G. A, BRUNNER, T, FRIZELLE, S. P, LISTON, J. C, SALERNO, C. T, KNAPP, D. J, GREEN, D. R, KRATZKE, R. A

    Published in Cancer research (Chicago, Ill.) (15-03-1997)
    “…To reach a clinically detectable size, neoplasms must be able to suppress or evade a host immune response. Activated T cells may enter apoptosis in the…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptase-polymerase chain reaction by Salerno, C T, Frizelle, S, Niehans, G A, Ho, S B, Jakkula, M, Kratzke, R A, Maddaus, M A

    Published in Chest (01-06-1998)
    “…The 5-year survival rate following surgical resection of Stage I or Stage II non-small cell lung carcinoma (NSCLC) is 30% to 50%, probably because of…”
    Get more information
    Journal Article
  9. 9

    Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer by ZHOU, Joan X, NIEHANS, Gloria A, SHAR, Alexander, RUBINS, Jeffrey B, FRIZELLE, Sandra P, KRATZKE, Robert A

    Published in Lung cancer (Amsterdam, Netherlands) (01-04-2001)
    “…Loss of the G1 checkpoint appears to be extremely common among virtually all neoplasms. A variety of genetic and epigenetic mechanisms have been demonstrated…”
    Get full text
    Journal Article
  10. 10

    Spontaneous and Evoked Measures of Pain in Murine Models of Monoarticular Knee Pain by Krug, Hollis E, Dorman, Christopher, Blanshan, Nicole, Frizelle, Sandra, Mahowald, Maren

    Published in Journal of visualized experiments (22-02-2019)
    “…Pain is the main cause of disability from arthritis. There is currently an unmet need for adequate treatments for arthritis pain. Pre-clinical models are…”
    Get more information
    Journal Article
  11. 11

    Inhibition of Both Mesothelioma Cell Growth and Cdk4 Activity following Treatment with a TATp16INK4a Peptide by FRIZELLE, Sandra P, KRATZKE, Marian G, CARREON, Richard R, ENGEL, Sean C, YOUNGQUIST, Laura, KLEIN, Mark A, FOURRE, Laura, SHEKELS, Laurie L, KRATZKE, Robert A

    Published in Anticancer research (01-01-2008)
    “…Disruption of the 9p21 locus is common in mesothelioma and leads to loss of both the p16 INK4a and the p14 ARF gene products. This study tested the hypothesis…”
    Get full text
    Journal Article
  12. 12

    The analgesic effect of intraarticular OnabotulinumtoxinA in a female murine model of collagenase induced chronic degenerative monoarthritis by Blanshan, Nicole, Mahowald, Maren L., Dorman, Christopher, Frizelle, Sandra, Krug, Hollis E.

    Published in Toxicon (Oxford) (01-02-2019)
    “…We previously reported the efficacy of intraarticular (IA) rimabotulinumtoxinB (BoNT/B) in a murine model of chronic degenerative arthritis pain. This study…”
    Get full text
    Journal Article
  13. 13

    Analgesic effects of intra-articular botulinum toxin Type B in a murine model of chronic degenerative knee arthritis pain by Anderson, Stephanie, Krug, Hollis, Dorman, Christopher, McGarraugh, Pari, Frizelle, Sandra, Mahowald, Maren

    Published in Journal of pain research (06-09-2010)
    “…To evaluate the analgesic effectiveness of intra-articular botulinum toxin Type B (BoNT/B) in a murine model of chronic degenerative arthritis pain. Chronic…”
    Get full text
    Journal Article
  14. 14

    Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression by FRIZELLE, S. P, GRIM, J, ZHOU, J, GUPTA, P, CURIEL, D. T, GERADTS, J, KRATZKE, R. A

    Published in Oncogene (18-06-1998)
    “…Absence of expression of the p16IKN4a gene product is commonly observed in mesothelioma tumors and cell lines, while wild-type pRB expression is maintained. We…”
    Get full text
    Journal Article
  15. 15

    Effects of Insulin-Like Growth Factor-1 Receptor Inhibition in Mesothelioma by Whitson, Bryan A., Jacobson, Blake A., Frizelle, Sandra, Patel, Manish R., Yee, Douglas, Maddaus, Michael A., Kratzke, Robert A.

    Published in The Annals of thoracic surgery (01-09-2006)
    “…Malignant mesothelioma is a devastating disease with a poor prognosis. Recent data have shown that insulin-like growth factor-1 receptor (IGF-1R) may play a…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Adenovirus-mediated delivery of p16 to p16-deficient human bladder cancer cells confers chemoresistance to cisplatin and paclitaxel by GRIM, J, D'AMICO, A, FRIZELLE, S, ZHOU, J, KRATZKE, R. A, CURIEL, D. T

    Published in Clinical cancer research (01-12-1997)
    “…We have previously established the efficacy of adenoviral gene delivery vectors for the treatment of bladder carcinoma in vivo. In the present work, we…”
    Get full text
    Journal Article
  19. 19

    Effects of insulin-like growth factor-1 receptor inhibition in mesothelioma. Thoracic Surgery Directors Association Resident Research Award by Whitson, Bryan A, Jacobson, Blake A, Frizelle, Sandra, Patel, Manish R, Yee, Douglas, Maddaus, Michael A, Kratzke, Robert A

    Published in The Annals of thoracic surgery (01-09-2006)
    “…Malignant mesothelioma is a devastating disease with a poor prognosis. Recent data have shown that insulin-like growth factor-1 receptor (IGF-1R) may play a…”
    Get full text
    Journal Article
  20. 20

    Mechanisms of G 1 checkpoint loss in resected early stage non-small cell lung cancer by Zhou, Joan X, Niehans, Gloria A, Shar, Alexander, Rubins, Jeffrey B, Frizelle, Sandra P, Kratzke, Robert A

    “…Loss of the G 1 checkpoint appears to be extremely common among virtually all neoplasms. A variety of genetic and epigenetic mechanisms have been demonstrated…”
    Get full text
    Journal Article